MU OPIOID RECPT; RBX-50UL

Code: AB5511 D2-231

Analysis Note

ControlSpinal cord, liver lysate

Application

Research Sub CategoryNeuroinflammation & Pain

Research CategoryNeuroscience

<...


read more

Your Price
€602.00 EACH
€740.46 inc. VAT

Analysis Note

ControlSpinal cord, liver lysate

Application

Research Sub CategoryNeuroinflammation & Pain

Research CategoryNeuroscience

Immunohistochemistry:
1:2,500-1:5,000 dilution of a previous lot was used.

Western blot:
1:1,000 dilution of a previous lot was used.

Immunocytochemistry:
1:2,500-1:5,000 dilution of a previous lot was used.

Optimal working dilutions must be determined by the end user.

Detect Opioid Receptor using this Anti-Opioid Receptor Antibody, µ, pain validated for use in IC, IH & WB.

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

General description

Opiates derived from the opium poppy, Papaver somniferum, have been used for millenia for their anti-diarrheal, analgesic and euphoric properties. More recently, endogenous peptides, enkephalins, dynorphins, and endorphins, were found to bind to the same sites as opiate alkaloids. The receptors for the classical opioids are three related GPCRs, δ, κ, and µ (also known as OP1, OP2 and OP3, respectively), that activate Gi/o to reduce intracellular cAMP levels. Although most clinically used opioids function by activation of the µ opioid receptor, agonists of spinal δ opioid receptors have antinociceptive activity that is independent of µ. In addition, activation of δ increases locomotor activity, inhibits gastrointestinal motility, and decreases respiratory frequency (Dhawan et al., 1996). Agonists for δ opioid receptors also exhibit antidepressant-like activity in animal models (Broom et al., 2002).

Immunogen

Synthetic peptide from the C-terminus of rat Mu Opioid receptor.

Epitope: C-terminus

Legal Information

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

Other Notes

Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.

Physical form

Rabbit polyclonal serum in buffer containing 0.05% sodium azide.

Unpurified

Quality

Evaluated by Western Blot on Human Liver lysate.

Western Blot Analysis:
1:500 dilution of this antibody detected Opioid Receptor on 10 µg of Human Liver lysate.

Specificity

Other species have not been tested.

Mu Opioid receptor.

Storage and Stability

Stable for 1 year at -20°C from date of receipt.

Target description

45 kDa

antibody formserum
antibody product typeprimary antibodies
biological sourcerabbit
clonepolyclonal
Gene Informationhuman ... OPRM1(4988)
manufacturer/tradenameChemicon®
NCBI accession no.NM_000914.2
Quality Level100
shipped indry ice
species reactivityhuman, primate, rat, mouse
technique(s)immunocytochemistry: suitable, western blot: suitable, immunohistochemistry: suitable
UniProt accession no.P35372
This product has met the following criteria to qualify for the following awards:



PROCEED TO CHECKOUT

HAVE AN ACCOUNT? LOGIN


GUEST CHECKOUT

Proceed as a guest. You will have the option to register to access exclusive pricing and stock availability features after checkout.